TriDerma recalls pain-relief cream due to lack of child-safe packaging

WASHINGTON, D.C. — TriDerma is recalling jars and tubes of its Pain Relief Cream with 4% Lidocaine, because the packaging is not child-resistant as required by the Poison Prevention Packaging Act, according to the U.S. Consumer Product Safety Commission.

The pain-relieving cream contains Lidocaine, which poses a poisoning risk to young children if they put it on their skin or ingest it, the CPSC says.

The 4-oz jar is white, with a lime green and pink label and a white cap. The 2.2-oz tube is white with a lime green and pink label. “TriDerma Pain Relief Cream” is printed on the jar and tube.

Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap.  TriDerma is contacting all known purchasers directly.
Here are the affected lot numbers and expiration dates:
Lot Number Expiration Date
21088 04/2021
20189 04/2021
0738F02A 06/2021
0738F04A 06/2021
0738F04B 06/2021
0738F04C 06/2021
0739A22A 01/2022
0739A22B 01/2022
0739A23A 01/2022
Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.